Suppr超能文献

复制蛋白 A 大亚基的功能获得性突变影响人 APOBEC 胞嘧啶脱氨酶在酵母中的诱变作用。

Hypomorphic mutation in the large subunit of replication protein A affects mutagenesis by human APOBEC cytidine deaminases in yeast.

机构信息

Genome Integrity & Structural Biology Laboratory, National Institute of Environmental Health Sciences, Durham, NC 27709, USA.

Department of Microbiology and Molecular Genetics, University of Vermont Cancer Center, University of Vermont, Burlington, VT 05405, USA.

出版信息

G3 (Bethesda). 2024 Oct 7;14(10). doi: 10.1093/g3journal/jkae196.

Abstract

Human APOBEC single-strand (ss) specific DNA and RNA cytidine deaminases change cytosines to uracils (U's) and function in antiviral innate immunity and RNA editing and can cause hypermutation in chromosomes. The resulting U's can be directly replicated, resulting in C to T mutations, or U-DNA glycosylase can convert the U's to abasic (AP) sites which are then fixed as C to T or C to G mutations by translesion DNA polymerases. We noticed that in yeast and in human cancers, contributions of C to T and C to G mutations depend on the origin of ssDNA mutagenized by APOBECs. Since ssDNA in eukaryotic genomes readily binds to replication protein A (RPA) we asked if RPA could affect APOBEC-induced mutation spectrum in yeast. For that purpose, we expressed human APOBECs in the wild-type (WT) yeast and in strains carrying a hypomorph mutation rfa1-t33 in the large RPA subunit. We confirmed that the rfa1-t33 allele can facilitate mutagenesis by APOBECs. We also found that the rfa1-t33 mutation changed the ratio of APOBEC3A-induced T to C and T to G mutations in replicating yeast to resemble a ratio observed in long persistent ssDNA in yeast and in cancers. We present the data suggesting that RPA may shield APOBEC formed U's in ssDNA from Ung1, thereby facilitating C to T mutagenesis through the accurate copying of U's by replicative DNA polymerases. Unexpectedly, we also found that for U's shielded from Ung1 by WT RPA, the mutagenic outcome is reduced in the presence of translesion DNA polymerase zeta.

摘要

人类 APOBEC 单链 (ss) 特异性 DNA 和 RNA 胞嘧啶脱氨酶将胞嘧啶转化为尿嘧啶 (U),并在抗病毒先天免疫和 RNA 编辑中发挥作用,可导致染色体发生超突变。产生的 U 可直接复制,导致 C 突变为 T,或 U-DNA 糖苷酶可将 U 转化为无碱基 (AP) 位点,然后由跨损伤 DNA 聚合酶将其固定为 C 突变为 T 或 C 突变为 G。我们注意到,在酵母和人类癌症中,C 突变为 T 和 C 突变为 G 的突变取决于 APOBEC 诱变的 ssDNA 的来源。由于真核基因组中的 ssDNA 容易与复制蛋白 A (RPA) 结合,我们想知道 RPA 是否会影响酵母中 APOBEC 诱导的突变谱。为此,我们在野生型 (WT) 酵母和携带大 RPA 亚基 rfa1-t33 部分缺陷突变的菌株中表达了人类 APOBEC。我们证实 rfa1-t33 等位基因可以促进 APOBEC 的突变。我们还发现 rfa1-t33 突变改变了复制酵母中 APOBEC3A 诱导的 T 突变为 C 和 T 突变为 G 的比例,类似于在酵母和癌症中长期存在的 ssDNA 中观察到的比例。我们提出的数据表明,RPA 可能会保护 ssDNA 中由 APOBEC 形成的 U 免受 Ung1 的影响,从而通过复制 DNA 聚合酶准确复制 U 来促进 C 突变为 T 突变。出乎意料的是,我们还发现,对于被 WT RPA 屏蔽的 Ung1 的 U,在存在跨损伤 DNA 聚合酶 ζ 的情况下,突变的结果会减少。

相似文献

7
Genetic inhibitors of APOBEC3B-induced mutagenesis.APOBEC3B 诱导的突变遗传抑制剂。
Genome Res. 2023 Sep;33(9):1568-1581. doi: 10.1101/gr.277430.122. Epub 2023 Aug 2.

本文引用的文献

3
APOBEC-Induced Mutagenesis in Cancer.载脂蛋白B编辑复合体诱导的癌症诱变
Annu Rev Genet. 2022 Nov 30;56:229-252. doi: 10.1146/annurev-genet-072920-035840. Epub 2022 Aug 26.
4
Mechanisms of APOBEC3 mutagenesis in human cancer cells.APOBEC3 在人类癌细胞中致突变的机制。
Nature. 2022 Jul;607(7920):799-807. doi: 10.1038/s41586-022-04972-y. Epub 2022 Jul 20.
7
Molecular origins of APOBEC-associated mutations in cancer.癌症中 APOBEC 相关突变的分子起源。
DNA Repair (Amst). 2020 Oct;94:102905. doi: 10.1016/j.dnarep.2020.102905. Epub 2020 Jul 6.
8
Hypermutation in single-stranded DNA.单链 DNA 中的高突变。
DNA Repair (Amst). 2020 Jul-Aug;91-92:102868. doi: 10.1016/j.dnarep.2020.102868. Epub 2020 May 18.
10
DNA polymerase ζ in DNA replication and repair.DNA 聚合酶 ζ 在 DNA 复制和修复中的作用。
Nucleic Acids Res. 2019 Sep 19;47(16):8348-8361. doi: 10.1093/nar/gkz705.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验